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Abstract
Inorganic polyphosphate (poly P) has been postulated to play a regulatory role in the transition to bacterial persistence. In
bacteria, poly P balance in the cell is maintained by the hydrolysis activity of the exopolyphosphatase PPX. However, the
Mycobacterium tuberculosis PPX has not been characterized previously. Here we show that recombinant MT0516 hydrolyzes
poly P, and an MT0516-deficient M. tuberculosis mutant exhibits elevated intracellular levels of poly P and increased
expression of the genes mprB, sigE, and rel relative to the isogenic wild-type strain, indicating poly P-mediated signaling.
Deficiency of MT0516 resulted in decelerated growth during logarithmic-phase in axenic cultures, and tolerance to the cell
wall-active drug isoniazid. The MT0516-deficient mutant showed a significant survival defect in activated human
macrophages and reduced persistence in the lungs of guinea pigs. We conclude that exopolyphosphatase is required for
long-term survival of M. tuberculosis in necrotic lung lesions.
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Introduction
It is estimated that 2 billion people worldwide have latent
tuberculosis (TB) infection, representing a vast potential reservoir
for subsequent reactivation disease, particularly in the setting of
the HIV pandemic [1]. Latent TB infection is believed to result
from the immunological control of a small number of nonreplicat-
ing and slowly metabolizing organisms [2], which have adapted to
the unfavorable microenvironmental conditions within lung
granulomas [3], likely including hypoxia [4], nutrient limitation,
and acidic pH [5]. These ‘‘dormant’’ bacilli exhibit phenotypic
tolerance to bactericidal antibiotics such as isoniazid [6], which
inhibits the mycolic acid synthesis pathway required for cell wall
synthesis [7,8]. Although previous studies have highlighted the
importance of various adaptive mechanisms in promoting the
long-term persistence of M. tuberculosis (Mtb) in host tissues,
including the stringent response [9,10] and a switch to utilization
of fatty acids as a source of carbon and energy through the
glyoxylate cycle [11], the Mtb molecular pathways underlying
latency remain largely undefined.
Inorganic polyphosphate (poly P), a linear polymer of many tens
or hundreds of inorganic phosphate residues linked by high-energy
phosphoanhydride bonds, has been postulated to play a regulatory
role in the transition to bacterial dormancy [12]. In bacteria, poly
P is synthesized by polyphosphate kinase (PPK), which catalyzes
the reversible transfer of the terminal (c) phosphate of ATP to poly
P [13]. The exopolyphosphatase PPX is involved in poly P
degradation and contributes to the maintenance of the poly P
dynamic balance in the cell [14]. During the Escherichia coli
stringent response, intracellular poly P levels increase significantly
as a result of inhibition of PPX activity by the alarmone (p)ppGpp
[14], which is synthesized by Rel when uncharged tRNA binds
nonenzymatically to the acceptor site of an elongating ribosome
stalled at a codon on an mRNA, signaling that the environment is
limited in amino acids [15]. Poly P induces expression of the rpoS
gene [16,17], which is also regulated by (p)ppGpp, and the
encoded RNA polymerase sigma factor RpoS directs the
transcription of .50 genes involved in cascades downshifting
growth and metabolism, thereby adjusting the cell to a persistent
state [18].
Recently, poly P has been shown to play an important role in
mycobacterial survival under various growth-limiting conditions.
A ppk1-deficient mutant of M. smegmatis was found to be defective
in poly P synthesis and more sensitive to surface stress, oxidative
stress, and extended anaerobic incubation, and a Rv2984 (ppk1)-
knockdown strain of Mtb with reduced intrabacillary poly P
content exhibited defective survival in THP-1 macrophages [19].
During stationary phase, ppk1 expression increases in M. smegmatis
[19], suggesting that poly P accumulation in mycobacteria may be
at least partially attributable to an increase in its biosynthetic rate.
In mycobacteria, poly P appears to induce the mprAB-sigE-rel
signaling pathway [19,20], indicating that poly P can control
(p)ppGpp synthesis through transcriptional regulation of rel.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28076We reasoned that Mtb must also have a PPX capable of poly P
hydrolysis, as in other bacteria [14], in order to maintain a
dynamic balance of intracellular poly P. Bioinformatic searches
predicted that the gene Rv0496/MT0516 encodes an enzyme
with exopolyphosphatase activity, which was confirmed experi-
mentally in the current study. An MT0516-deficient recombinant
mutant (MT0516::Tn) was generated to study the role of PPX in
Mtb growth in axenic cultures and in human macrophages, as well
as the effect of PPX deficiency on antibiotic tolerance. To
determine the impact of poly P accumulation on Mtb pathogenesis
in the animal host, we studied the growth, survival, and pathology
of the MT0516-deficient mutant in the guinea pig model of
chronic TB infection.
Results
Homology-based identification of putative M.
tuberculosis exopolyphosphatases
Based on homology searches of the M. tuberculosis genome [21],
the genes Rv0496/MT0516 and Rv1026/ MT1054 were
predicted to encode exopolyphosphatases, consistent with earlier
predictions by Lindner et al. [22]. Pfam HMM E-values (2.2e
294
and 1.2e
291, respectively) localized the proteins to the 2065-
membered single-domain Ppx-GppA family (PF02541), which is
global among prokaryotes. Three dimensional structural modeling
against the PHYRE template database [23] was used to predict the
most likely PPX to hydrolyze poly P. MT0516 has structural
homology to the first 2 domains of E. coli O157:H7 PDB 2FLO at
100% precision [24] and E-value 3e
240 (Fig.1) while MT1054 has
structural homology to Aquifex aeolicus PDB 2J4R at 100%
precision [25] and E-value 1.2e
238. We hypothesized that
MT0516, a nonessential gene, encoded an exopolyphosphatase
hydrolyzing poly P, whereas MT1054, an essential gene, encoded
a (p)ppGppase. It is of interest that both genes are present in the
M. leprae minimal genome required for slow growth in human
tissues [26].
Deficiency of MT0516 leads to poly P accumulation,
growth restriction, and antibiotic tolerance
In order to test the role of MT0516 in M. tuberculosis regulation
of poly P content and bacillary growth, an MT0516-deficient
mutant (MT0516::Tn) previously generated using transposon
mutagenesis of Mtb CDC1551 [27] was used in this study. The
MT0516 gene and flanking sequences were then cloned into
MT0516::Tn to generate a complement strain (MT0516 Comp;
Fig.2A), which was used to confirm that mutant phenotypes were
in fact attributable to MT0516 deficiency. PCR amplification of a
region of MT0516 revealed a product of the correct size in wild
type and MT0516 Comp strains (Fig.2B). Additionally, MT0516
Comp can be distinguished genetically from wild type by the
presence of a kanamycin-resistance cassette in the former, which is
also present in MT0516::Tn, and by the presence of a unique
hygromycin-resistance cassette (Fig.2B). Integration of MT0516 at
the proper location is expected to produce a 1.8-kb restriction
fragment compared to a 5.8-kb restriction fragment in the wild
type following digestion with EcoRI (Fig.2C). These findings were
further corroborated by Southern blot (Fig.2D) using a DNA
probe recognizing the region shown in Fig.2C.
If MT0516 encodes a PPX, we reasoned that deficiency of
MT0516 would lead to Mtb poly P accumulation. Mtb poly P was
extracted from axenic cultures of MT0516::Tn, MT0516 Comp,
and wild-type strains using previously described methods [19,28],
and a DAPI-based fluorescence technique [29] was used to
measure intrabacillary poly P. As shown in Fig.3A, poly P levels
were low in the wild-type and MT0516 Comp strains during mid-
logarithmic growth phase, reaching a peak during late-logarith-
mic/early-stationary phase, and then declined again in late
stationary phase, as has been described in other organisms
[30,31]. In contrast, the intrabacillary content of poly P was
significantly elevated in MT0516::Tn during mid-log phase and
was maintained at this level throughout the growth cycle,
consistent with the predicted role for MT0516 in poly P hydrolysis.
To determine if increased poly P levels in MT0516::Tn were
associated with poly P-mediated signaling, we studied the
expression of the mprAB-sigE-rel regulatory cascade, which has
been shown to be induced in mycobacteria by poly P [19,20].
Relative to exponentially growing wild-type cultures, growth-
phase-matched cultures of MT0516::Tn showed increased expres-
sion of mprB, sigE, and rel by RT-PCR, consistent with poly P-
mediated signaling in the mutant (Fig.3B). Expression of Rv2984/
MT3062 (ppk1) was downregulated and the expression of Rv1026/
MT1054 (putative ppx) was upregulated in the MT0516-deficient
mutant, consistent with regulatory feedback mechanisms to
compensate for elevated intrabacillary poly P levels.
It has been postulated that poly P accumulation may serve as a
transient molecular signal for bacterial entry into persistence [13].
We hypothesized that premature poly P-mediated signaling would
lead to Mtb growth restriction and phenotypic tolerance to
bactericidal drugs. Consistent with our hypothesis, axenic liquid
cultures of MT0516::Tn showed decelerated growth relative to
that of wild-type and complement cultures (Fig.3C). Similarly,
MT0516::Tn demonstrated a small-colony phenotype on 7H10
solid agar when plates were evaluated 28 days after incubation
(Fig.3D). To determine if MT0516 deficiency is also associated
with impaired growth within human monocytes, THP-1 cells were
activated and infected with wild type, MT0516::Tn, or MT0516
Comp. Although wild type and MT0516 Comp showed equivalent
growth in activated THP-1 cells by Day 5 after infection,
MT0516::Tn showed a significant growth defect relative to the
wild type and complement strains (p=0.001), which was further
magnified by Day 7 after infection (p,0.001; Fig.3E).
Figure 1. Protein modeling predicts that M. tuberculosis MT0516
is an exopolyphosphatase. The protein backbone ribbon structure
was modeled by PHYRE [23], showing the conserved hydrolase fold
associated with exopolyphosphatases. Left-angled, top-down view of
the interface canyon between domains I and II with the a helix 4 (within
box) that houses the highly conserved active site E112 side chain
opening into the canyon floor. The canyon walls are lined with b sheets.
doi:10.1371/journal.pone.0028076.g001
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promoting phenotypic tolerance to antibiotics, we tested the activity of
the bactericidal drug isoniazid against MT0516::Tn relative to the
wild-type strain. Consistent with the hypothesis that poly P
accumulation retards Mtb growth, the MIC of isoniazid against
MT0516::Tn increased from 0.03 mg/ml, as observed for the isogenic
wild-type strain, to 0.25 to mg/ml (Table1). On the other hand,
MT0516::Tn showed equivalent susceptibility to rifampin relative to
the wild-type strain as the MIC remained unchanged (0.25 mg/ml).
These studies were performed three times with identical results.
We hypothesized that dysregulated poly P-mediated signaling,
in addition to resulting in early growth restriction and antibiotic
tolerance, might also impair long-term survival of Mtb under
growth-restricting conditions. The wild-type, MT0516::Tn, and
MT0516 Comp strains were subjected to progressive hypoxia in
vitro [32,33]. By 42 days after entry into nonreplicating persistence
stage 2 (NRP-2), when the dissolved oxygen drops to ,0.06% and
bacilli exhibit reduced susceptibility to standard antituberculous
drugs [32,34], MT0516::Tn showed a significant survival defect
relative to the isogenic wild-type strain (p=0.002) (Fig.3F).
Figure 2. Complementation of transposon mutant MT0516::Tn. A. Diagram of expected recombination between integrating plasmid and
genomic DNA. B. PCR analysis of genomic DNA. A list of relevant primers is included in Table1. Lane 1: Molecular weight markers. Lanes 2-4:
Amplification of the MT0516 gene from wild-type, MT0516::Tn, and MT0516::Tn Comp, respectively. The expected 1035-bp PCR product is present in
Lanes 2 and 4 but absent in Lane 3. Lane 5: Molecular weight markers. Lanes 6-8: Amplification of the kanamycin resistance cassette from wild type,
MT0516::Tn and MT0516::Tn Comp, respectively, yielding the expected 226-bp product only in Lanes 7 and 8. Lane 9: Molecular weight markers.
Lanes 10-11: Amplification of the hygromycin resistance cassette from MT0516::Tn and MT0516::Tn Comp, respectively, yielding the expected 319-bp
product only in Lane 11. C. Diagram of expected sizes of EcoRI-digested genomic fragments expected to hybridize to probe recognizing region of
MT0516 coding sequence by Southern blot (D). Note that MT0516::Tn Comp is expected to have two different size fragments hybridizing to the
MT0516 probe, including that found in MT0516::Tn (1.8 Kb) and a distinct fragment unique to the attB integration site (1.7 Kb). D. Southern blot
detecting the presence of DNA fragments bound to the MT0516 hybridization probe. Lane 1: Molecular weight markers. Lane 2: Blank. Lanes 3-5: Wild
type, MT0516::Tn, and MT:0516::Tn Comp, respectively.
doi:10.1371/journal.pone.0028076.g002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e28076Figure 3. MT0516 deficiency results in persistently elevated intrabacillary levels of poly P and impaired growth in axenic cultures
and macrophages. A. Intrabacillary poly P content expressed as ng of poly P per mg of bacterial protein in each strain during different stages of the
growth cycle in nutrient-rich broth (**p,0.01). B. RT-PCR analysis of gene expression in MT0516::Tn expressed as change in cycle threshold relative to
that of the isogenic wild-type strain during mid-log phase growth in nutrient-rich broth. C. Growth of each strain in nutrient-rich 7H9 broth. D. Colony
size of each strain on 7H10 solid media determined 28 days after plating. E. Growth and survival of each strain in THP-1 cells (**p,0.001). F. Growth
and survival of each strain during exposure to progressive hypoxia in vitro (**p ,0.001). CDC1551= wild type; MT0516::Tn= MT0516-deficent
mutant; MT0516::Tn Comp= MT0516::Tn complement strain. CFU = colony-forming units. NRP-2= Nonreplicating persistence stage 2, as
determined by color change of methylene blue dye.
doi:10.1371/journal.pone.0028076.g003
Table 1. Sequence of primers used in this study.
Gene/region amplified Primer sequence
MT0516 Forward59-cgcggatccggtgcgattggg-39 Reverse 59-ccgctcgagtggtttcgtgcc -39
kan
R Forward 59-atgcctcttccgaccatcaagcattt-39 Reverse 59-attgcgcctgagcgagacgaaata-39
hyg
R Forward 59-atctcgcggtcgccccgga-39 Reverse 59-tgctcaccccccattccgaggt-39
MT0516 Probe Forward 59-ggtgtcgagttgcaggc-39 Reverse59-gccaacgagcgaaacgt-39
mprB Forward-59-tacccaagcaggagatggtc-39 Reverse-59-cataaacctgccacccaatc-39
Rel Forward-59-gggtgctggtgataaaggtg-39 Reverse-59-aggtcctccaactcccactt-39
MT0516 Forward59-cgcggatccggtgcgattggg-39 Reverse 59-ccgctcgagtggtttcgtgcc-39
sigE Forward-59-accatcacgaccttgagtcc-39 Reverse-59-aggtctcctgggtcaggtct- 39
ppk1 Forward-59-ctcaagacgcactgcaagac -39 Reverse-59-tgaacaagtcggtcaagtcg -39
MT1054 Forward-59-gactgcggtaccaactcgat-39 Reverse-59-tggtgaaacgtcagcagttc-39
doi:10.1371/journal.pone.0028076.t001
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and persistence in guinea pig lungs
The guinea pig model was used to assess the impact of poly P
accumulation on Mtb growth and survival within necrotic lung
granulomas, which exhibit tissue hypoxia [35,36]. Guinea pigs
were aerosol-infected with wild type, MT0516::Tn, or MT0516
Comp. During the first 14 days after infection, wild-type and
MT0516 Comp strains showed typical exponential growth,
reaching a peak lung burden of 6.6760.02 log10 and 6.5360.11
log10, respectively (Fig.4A). On the other hand, MT0516::Tn
showed a mild but statistically significant initial growth defect
relative to wild type, increasing to only 6.1960.04 (p=0.001).
After the onset of adaptive immunity, the wild type maintained a
relatively stable lung census at Days 56 and 84. The lung CFU of
MT0516::Tn-infected animals declined slightly to 5.660.07 log10
at Day 28 (p=0.001), decreasing further to 5.2960.28 log10 (p =
0.01) at Day 56 and 4.6460.11 log10 (p=0.001) at Day 84.
Reintroduction of MT0516 in the complemented strain mostly
restored the wild-type growth and survival phenotypes.
All guinea pigs gained weight throughout the experiment,
although mean body weight gain between Days 56 and 84 was
greatest in the mutant-infected group (454.9626.8 g to
525.5639.7 g in MT0516::Tn-infected guinea pigs vs.
442.6638.9 g to 487.5655.4 g in wild-type-infected guinea pigs,
and 478.8655.7 g to 483.0644.3 g in MT0516::Tn Comp-
infected guinea pigs). In addition, by week 13 after infection, 3
of 4 animals in the wild-type group, but none in the other groups,
became moribund with reduced activity and increased respiratory
rate, resulting in early termination of the experiment. Guinea pig
lung weights in wild-type and MT0516 Comp groups were
6.9961.50 g and 7.8161.75 g, respectively, on Day 56 and
9.9261.83g and 8.5360.93 g, respectively, on Day 84. In
contrast, lung weights of MT0516::Tn-infected animals were only
4.7560.81 g on Day 56 and 6.4060.71 on Day 84 (p=0.04 at
Day 56 and p=0.01 at Day 84, as compared to wild type). Gross
examination of lungs infected with wild-type and MT0516 Comp
strains on Day 84 revealed discrete tubercle lesions distributed
throughout the lung surface (Fig.4B), while MT0516::Tn-infected
lungs revealed markedly reduced inflammation without discrete
lesions.
Histological examination of Day 84 guinea pig samples infected
with wild-type and MT0516 Comp strains revealed significant
lung involvement, with areas of peribronchiolar inflammation and
multiple well-circumscribed granulomas comprising primarily
lymphocytes and histiocytes with central necrosis (Fig.4C). Ziehl-
Neelsen staining revealed the presence of multiple acid-fast bacilli
in the periphery of granulomas (Fig.4C inset). In contrast,
histological evaluation of MT0516::Tn-infected lung samples
revealed significantly reduced inflammation overall (Fig.4C) and
acid-fast bacilli could not be identified in these lung samples.
Figure 4. MT0516 is required for full virulence of Mtb in guinea pigs. A. Growth and survival of the mutant following low-dose aerosol
infection in guinea pig lungs relative to wild-type and complement strains (*p#0.01; **p#0.001 for differences in bacillary counts between mutant-
and wild-type-infected lungs). B. Gross pathology of Mtb-infected guinea pig lungs at Day 84 after aerosol infection. C. Microscopic examination of
Mtb-infected lungs at Day 84 (H&E stain, 26 magnification. Insets: Ziehl-Neelsen staining, 50x magnification. CDC1551= wild-type strain;
MT0516::Tn= MT0516-deficent mutant; MT0516::Tn Comp= MT0516::Tn complement strain.
doi:10.1371/journal.pone.0028076.g004
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To confirm the activity of MT0516 as a PPX and further
characterize its enzymatic properties, we expressed and purified it
from E. coli as an N-terminal 6X-His fusion protein. A protein of
the predicted size (36.6 KDa) was identified in the elution fraction
by SDS-PAGE analysis (Fig.5A), and the identity of recombinant
MT0516 was confirmed by Western blot using antibody directed
against 6X-His (Fig.5B), as well as by liquid chromatography
tandem mass spectrometry (LCMS; data not shown).
Calf intestine-derived alkaline phosphatase was used as a
positive control for the PPX assays. As shown in Figure5C,
recombinant MT0516 demonstrated concentration-dependent
PPX activity, as 1 mg of the recombinant protein hydrolyzed
,57% of poly P (p ,0.001relative to negative control), and 2 mg
of protein hydrolyzed ,78% of poly P after 4 hours of incubation
with substrate. In addition, the recombinant protein exhibited
time-dependent PPX activity (Figure5D), hydrolyzing ,51% of
poly P by 4 hrs (p,0.001 relative to 0 hrs), and ,75% of poly P by
12 hrs (p ,0.01relative to 4 hrs). On the other hand, an equal
concentration of protein obtained from the supernatant of IPTG-
induced Arctic E. coli transformed with the empty vector revealed
no PPX activity (Fig.5D).
Certain PPXs have a GppA-like activity, cleaving the terminal
(c) phosphate from pppGpp and generating ppGpp [37]. Although
modeling experiments did not predict a (p)ppGpp binding cleft in
MT0516, we tested the recombinant protein for ppGppase
activity. Unlike alkaline phosphatase, recombinant MT0516 did
not cleave ppGpp as assessed by HPLC (data not shown). During
stress conditions, other bacteria have been shown to increase their
poly P content through (p)ppGpp-mediated inhibition of PPX
[14]. However, the poly P-hydrolyzing activity of MT0516 was not
inhibited by ppGpp (data not shown).
Discussion
Poly P was originally identified as metachromatically stained
‘‘volutin granules’’ in microbes, and subsequently found to be
abundant in every cell in nature [38]. Dismissed as a ‘‘molecular
fossil’’ for many years, poly P has been implicated in many
important cellular functions, including serving as an alternative
Figure 5. Recombinant MT0516 exhibits concentration- and time-dependent exopolyphosphatase activity. A. Polyacrylamide gel
electrophoresis showing the fractions of recombinant His-tagged MT0516 protein (36.6 KDa), expressed in E.coli Arctic Express (DE3) BL 21. Lane 1:
Molecular weight markers; Lanes 2-3: Supernatant and pellet, respectively, prior to Ni
++NTA column binding; Lanes 4-5: Elution fraction 1 and 2,
respectively, eluted sequentially from Ni
++NTA column. B. Western blot using Penta-His antibody. Lane 1: Molecular weight markers. Lane 2: Elution
fraction 2 after native purification demonstrating the expected size band (36.6 KDa). C. Exopolyphosphatase activity of recombinant MT0516
expressed as % hydrolysis of substrate (65-mer poly P) as a function of protein concentration (mg/ml). **p ,0.001. D. Exopolyphosphatase activity of
recombinant MT0516 expressed as % hydrolysis of substrate (65-mer poly P) as a function of time (hours). E= elution fraction 2; AP= alkaline
phosphatase (positive control); NC= negative control comprising supernatant obtained following IPTG induction of Arctic E coli transformed with
empty vector. In each reaction, 1 mg/ml poly P was used as substrate. Data for Fig. 5C and 5D are derived from individual experiments, each of which
was performed three times with separate samples yielding similar results.
doi:10.1371/journal.pone.0028076.g005
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chelation of cationic metals (e.g., Mn
2+,M g
2+,C a
2+), buffer
against alkali, environmental remediation of phosphate, and
regulation of growth, development, and response to stress
conditions [13]. The presence of poly P was documented in Mtb
more than five decades ago [39], but its role in Mtb virulence
remains uncharacterized. Supporting a potential role for poly P as
a growth regulatory molecule in Mtb, recent studies found that
that the expression of Rv2984, encoding the poly P kinase PPK1,
is induced during stationary phase [19] and inorganic phosphate
starvation [40]. In this study, we have identified another
mechanism for Mtb regulation of intrabacillary poly P levels
through expression of Rv0496/MT0516, which encodes a PPX
responsible for poly P hydrolysis.
To our knowledge, this is the first report to establish a direct link
between poly P accumulation and phenotypic tolerance of bacteria
to antibiotics. This phenomenon was originally described four
decades ago [41], and refers to the observation that non-dividing
bacteria become less susceptible to killing by cell wall-active
antibiotics, which target actively multiplying organisms. In our
study, deficiency of the Mtb PPX led to accumulation of poly P
and restricted growth in axenic cultures and in human
macrophages, as well as reduced susceptibility to killing by the
bactericidal drug isoniazid [6], which inhibits the mycolic acid
synthesis pathway [7,8] required for cell wall synthesis. We found
evidence of poly P-mediated signaling through the recently
described mprAB-sigE-rel regulatory pathway [19], suggesting that
poly P accumulation triggers the stringent response, which is
characterized by dramatically reduced growth, decreased rRNA,
tRNA, and protein synthesis, modified RNA polymerase activities,
diminished activity of many transport systems, and decreased
carbohydrate, amino acid, and phospholipid metabolism [15,42].
On the other hand, elevated intrabacillary levels of poly P did not
alter susceptibility to rifampin, which targets RNA polymerase
[43]. The reduced susceptibility of Mtb to isoniazid during human
latent TB infection has long been recognized [6], and the relatively
greater activity of rifampin against these bacilli is reflected in
clinical guidelines, which recommend 9 months of isoniazid or 4
months of rifampin for treatment of latent TB infection [44]. The
superior activity of rifampin against nonreplicating bacilli relative
to isoniazid also has been observed upon exposure of Mtb to
progressive hypoxia [32] and nutrient starvation [45], as well as in
animal models of latent TB infection [46,47]. Whether poly P
accumulation alone is sufficient to induce Mtb growth restriction
and antibiotic tolerance remains to be proven using an Mtb
recombinant strain conditionally overexpressing the ppk1 gene.
The effect of poly P accumulation on bacterial efflux pumps whose
induction has been shown recently to induce drug tolerance in
mycobacteria [48] is also a subject of future study.
Our data suggest that poly P accumulation may serve as a
transient molecular signal for Mtb growth restriction, as
intrabacillary levels of poly P peaked in wild-type Mtb prior to
entry into stationary phase, as reported in other bacteria [14].
Interestingly, persistently elevated levels of poly P were associated
with reduced Mtb persistence during progressive hypoxia and in
necrotic granulomas in guinea pigs. Recent studies have shown
that antisensing of Rv2984 (ppk1) in Mtb leads to reduced
intrabacillary poly P content and reduced survival in THP-1
macrophages [19]. Together, these findings suggest that dysreg-
ulation of the intrabacillary poly P balance results in reduced Mtb
survival during stress conditions. Consistent with tight regulation
of poly P levels in bacteria, overexpression of E. coli ppk and ppx
leads to poly P accumulation and depletion, respectively, and, in
both cases, to loss of viability [13].
The E. coli genes ppk and ppx comprise an operon, which is
regulated by the two-component response regulator PhoB under
inorganic phosphate-limited conditions [49]. In contrast, the Mtb
genes ppk1 (Rv2984/MT3062) and ppx (Rv0496/MT0516) are
located at genetically distinct loci. Expression of ppk1 in Mtb may
be dependent on RegX3, which is a homolog of E. coli PhoB and
appears to regulate the Mtb phosphate starvation response [40].
On the other hand, despite the genomic proximity of MT0516 to
regX3 (Rv0491/Mt0510), MT0516 expression does not appear to
be RegX3-dependent [40]. Bioinformatic analysis suggests that
MT0516 is the first gene of a multi-gene operon, which could
explain the incomplete restoration of the wild-type phenotype of
MT0516::Tn Comp in all assays tested in this study due to
potential polar effects on downstream gene expression in
MT0516::Tn. Alternatively, native regulation of MT0516 expres-
sion may have been altered by integration of MT0516 at the attB
site in MT0516 Comp. In other bacteria, accumulation of poly P
appears to be mediated through induction of the stringent
response and (p)ppGpp-mediated inhibition of PPX activity [14].
In our study, we did not observe inhibition of recombinant
MT0516 by ppGpp, suggesting that poly P accumulation in
mycobacteria may be regulated primarily through an increase in
its biosynthetic rate, as suggested by previous reports [19].
In addition to hydrolyzing poly P, PPX has been implicated
directly in bacterial virulence. Recently, a mutant of Neisseria
meningitides lacking PPX was found to exhibit increased resistance
to complement-mediated killing independent of structural changes
in the capsule, lipopolysaccharide, and factor H-binding protein,
which are known to be required for evasion of the complement
system [50]. A ppx null mutant of Bacillus cereus was found to be
defective in motility, biofilm formation, and sporulation efficiency
[31]. While most bacteria appear to have a single PPX, deficiency
of which leads to a strong mutant phenotype, it seems likely that
Mtb has multiple enzymes with PPX activity. Increased expression
of MT1054/Rv1026 in the MT0516-deficient mutant raises the
interesting possibility that MT1054 can compensate for the lack of
MT0516/Rv0496, perhaps limiting the accumulation of poly P
and leading to an intermediate phenotype. Current research is
focused on characterizing the enzymatic activity of MT1054/
Rv1026, and the phenotype of an MT1054 conditional knock-
down strain, as well as that of a MT0516/MT1054 double
mutant.
In addition to the previously characterized antigens ESAT-6,
CFP10, Ag85A, and Ag85B, Rv0496 was identified as a novel
secreted T-cell antigen, which is recognized by peripheral blood
mononuclear cells derived from close contacts of TB patients with
positive tuberculin skin tests [51]. These data suggest that
MT0516/Rv0496 is expressed by M. tuberculosis during human
latent TB infection, raising the possibility that this antigen, like
ESAT-6 and CFP10, could be used to diagnose latently-infected
individuals. Although poly P is present in all cells, enzymes
homologous to Mtb PPX are absent in eukaryotes, suggesting that
the latter may represent an attractive drug target. Since PPX is
required for Mtb persistence in necrotic lung lesions, it is possible
that a small molecule inhibitor to this enzyme may target
‘‘persister’’ bacilli, thereby contributing to shortening of TB
treatment.
Materials and Methods
Ethics Statement
All procedures involving animals were performed according to
protocols approved by the Institutional Animal Care and Use
Committee at the Johns Hopkins University (JHU protocol
Poly P-Mediated Persistence and Tolerance in Mtb
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e28076approval number GP09M68). All guinea pigs were maintained
and bred under specific-pathogen-free conditions and fed water
and chow ad libitum.
Bacterial strains and growth conditions
The JHU standard reference strain of M. tuberculosis CDC 1551
strain was used in all experiments as the wild-type control and was
the host strain used for mutagenesis with the Himar1 transposon, as
previously described [27]. A mutant with a transposon insertion in
MT0516/Rv0496 (MT0516::Tn) was identified in our archived
library, and the transposon insertion site was determined to be at
bp 732 (total gene length = 1035 bp), as previously described
[27,52]. For construction of the complement strain (MT0516
Comp), genomic DNA was isolated from M. tuberculosis CDC1551
according to standard protocols [53]. A 1235-bp region encom-
passing the MT0516 gene and 200-bp sequence upstream of the
putative transcription start sequence was PCR-amplified using
forward primer 59-GGG GAC AAG TTT GTA CAA AAA AGC
AGG CTT CCC ACC CAC TCA CGG GCG AA-39and reverse
primer59- GGG GAC CAC TTT GTA CAA GAA AGC TGG
GTC CTG GCC AGC AAC TCG GC- 39. The amplified
sequence was cloned into pDONR vector (Invitrogen) and then
into the Entry vector pGS202 by a series of homologous
recombination steps using the Gateway cloning system (Invitrogen)
and transformed into E. coli DH5a according to the manufactur-
er’s instructions. Transformants were selected on hygromycin-
supplemented LB agar and the identity of the clones was
confirmed by DNA sequencing. Plasmid DNA from positive
clones was electoporated into MT0516::Tn competent cells
according to standard protocols, as previously described [53].
The transformants were plated on Middlebrook 7H10 plates
supplemented with hygromycin (100 mg/ml) and kanamycin
(50 mg/ml). The identity of MT0516 Comp was confirmed by
PCR and Southern blot (Fig.2).
Eachstrain was grown in Middlebrook 7H9 broth (Difco, Sparks,
MD) supplemented with 10% oleic acid-albumin-dextrose-catalase
(OADC, Difco), glycerol, 0.05% Tween 80 at 37uC on a roller. The
growth of each strain was assessed at designated intervals by
measuring the optical density at 600nm and by plating samples on
Middlebrook 7H10 plates (Difco, Sparks, MD). Colony-forming
units (CFU) were enumerated after incubation of plates for 4 weeks
at 37uC, and the colony morphology was recorded.
Cloning, expression, and purification of recombinant His-
tagged MT0516
A 1035-bp region encompassing the full-length MT0516 gene
was amplified from M. tuberculosis CDC1551 DNA using forward
primer 59-ccgctcgaggtgcgattgggcgtgct -39 and reverse primer 59-
cgcggatcctcatggtttgctgcctc -39and the Xho I-BamH I-digested
fragment was cloned into T7 plasmid pET15b containing an N-
terminal 6X-His tag (Novagen). The resulting expression plasmid,
MT0516/pET was used to transform E. coli Arctic Express (DE3)
RP competent cells (Stratagene). Empty vector lacking the
MT0516 gene were used to mock transform and construct
negative control strain. The transformed bacteria were plated and
colonies were isolated on LB agar supplemented with ampicillin
(100 mg/ml). Positive clones were confirmed by sequencing and
were grown in LB broth supplemented with gentamycin (20 mg/
ml) and ampicillin (100 mg/ml) and the recombinant protein was
overexpressed upon induction with 1mM IPTG. Cells were
harvested after 24 hours of induction at 9uC and stored overnight
at -20uC. Mock-transformed cells were also induced with 1mM
IPTG and the cell supernatant was dialyzed and used as negative
control in subsequent experiments.
The protein was purified under native conditions according to
standard protocol (Qiagen). The dialyzed active protein fractions
were quantified using Bradford reagent (Sigma) and analyzed by
SDS-PAGE. A Western blot was performed to confirm the identity
of recombinant MT0516 using Penta His Antibody (Qiagen)
directed against 6X-His according to the manufacturer’s instruc-
tions. The active fractions were frozen and stored at 280uC until
use.
Analysis of recombinant MT0516 by mass spectrometry
The 36.6 KDa band from SDS gel and the elution fraction after
native purification of recombinant protein were reduced and
alkylated with iodacetamide and proteolyzed with sequencing-
grade modified procine trypsin (Promega). Protein identification
by liquid chromatography tandem mass spectrometry (LCMS)
analysis of peptides was performed using an LTQ ion trap MS
(Thermo Fisher scientific), interfaced with a 2D nanoLC system
(Eksigent). Peptides were fractionated by reverse phase HPLC on a
75 mm X100mm C18 column with a 10 mm emitter using 0-60%
acetonitrile/0.1% formic acid gradient over 90 min at 300nl/min.
Peptide sequences were identified using Mascot software to
search the NCBI nr 167 database with acquired raw MS data,
with oxidation on methionine and carbamidomethylation on
cysteine as variable modifications. Mascot search result *.dat files
were processed in Scaffold to validate protein and peptide
identifications.
Extraction and measurement of intrabacillary poly P
content
Mtb strains MT0516::Tn, MT0516 Comp, and the isogenic
CDC1551 wild-type strain were grown in Middlebrook 7H9 broth
(Difco, Sparks, MD) supplemented with 10% oleic acid-albumin-
dextrose-catalase (OADC, Difco), glycerol, 0.05% Tween-80,at
37uC on a roller. At regular intervals samples were collected and
poly P was extracted. Briefly, bacterial cultures were diluted to an
OD of0.45to 0.5at regular timepoints, pelleted and lysed using 5M
guanidine isothiocyanate (GITC)-50 mM Tris-HCl, pH 7.0 (GITC
lysis buffer)prewarmedto 95uC. Following brief sonication, samples
from each experimental group and control were removed for
protein estimation [54]. Poly P was purified using glass milk beads
from the Geneclean III kit (MP Biomedicals LLC) and eluted in
warm water (pH 8.0) [13], and the eluted mixture was treated with
DNase and RNase. PCR of the sigA gene confirmed the absence of
detectable DNA contamination in all samples.
AD A P I( 4 9,6-diamidino-2-phenylindole)-based assay capable of
detecting poly P concentrations in the ng/ml range [29] was used
for poly P measurements. Briefly, the flourescent dye DAPI binds to
poly P and when the DAPI-polyP complex is excited at 415 nm,
peak fluorescence is emitted at 525 nm. At this wavelength there is
very little background emission from either free DAPI or DAPI-
DNAcomplex[29].TheminimumconcentrationofpolyPdetected
by this method is 25 ng/ml. For the generation of a standardized
curve,1 mg/mlDAPI (RocheDiagnostics)was incubatedfor10min
at room temperature with increasing concentrations of poly P
(average 65-mer, Sigma). The shift in fluorescence was measured by
FLUOstar OPTIMA (BMG LABTECH) at 415nm (excitation) and
525nm (emission) wavelengths.
Assay of poly P and (p)ppGpp hydrolysis activity of
recombinant MT0516
The pooled, dialyzed elution fraction containing recombinant
MT0516 was used to assay for poly P hydrolysis activity. Briefly,
the elution fraction containing 1.0 mg/ml of recombinant MT0516
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buffer (10 mM MgCl2,1.5 mMKCl)pH 8.0for12 hr.Calfintestine-
derived alkaline phosphatase (100 U, New England Biolabs) was used
as a positive control for these reactions. The poly P concentration of
triplicate samples was quantified at designated time points, using the
DAPI-based fluorescence assay described above.
To determine the effect of ppGpp on the activity of recombinant
MT0516, the reaction was repeated with addition of 10 mM ppGpp
and incubated for 12 hrs before measuring residual poly P in the
mixture. ppGpp (1 mM; TriLink BioTechnologies, San Diego, CA)
was incubated with the elution fraction of recombinant MT0516
(1 mg/ml) for 30 min in 50 mM Tris HCl buffer pH 7.5. Antarctic
phosphatase (100 U) was used as a positive control. 20 ml of sample
from each reaction was injected into a reverse-phase HPLC (Waters
2690) fitted with Sunfire C18 column and a UV detector (Waters
2487),tostudy the hydrolysisof ppGpp and theresultingpeaks were
analyzed with Chrom Perfect software.
Gene expression analysis by RT-PCR
50-ml samples were removed from logarithmically-growing
cultures at mid-log phase, (OD=0.45-0.5) and centrifuged at
3500 rpm for 10 minutes at 4uC. The supernatants were removed
and the pellets were resuspended in 1 ml TriZOL reagent
(GIBCO/BRL). Mycobacterial membranes were disrupted using
0.1 mm zirconia/silica beads in a Bio-Spec bead beater (8 cycles x
30 sec/cycle). Mycobacterial RNA was recovered by centrifuga-
tion, chloroform extraction, and isopropyl alcohol precipitation, as
previously described [46]. Prior to reverse transcription, control
and mutant RNA (10 ng) were treated with RNase-free DNase
(Invitrogen) and subjected to 36 cycles of PCR to ensure that all
DNA had been removed, as assessed by ethidium bromide-stained
agarose gel analysis. Fluorescently-labeled cDNA was generated
using Superscript III (Invitrogen), using fluorescent dyes Cy3 and
Cy5 (Amersham). cDNA corresponding to each transcript was
subjected to 34 cycles of PCR for quantification using the primers
listed in Table1. The cycle threshold value (CT) obtained for each
gene of interest (GOI) was normalized with that of sigA,a
housekeeping gene (HKG) with constant expression under
different experimental conditions [55], in order to obtain the
normalized CT (nCT = (GOI CT) – (HKG CT)). The change in
CT (DCT) was calculated using the following formula: (DCT =
C(nCT) – S(nCT)), where C represents the control strain and S
represents MT0516::Tn. The experiment was repeated three times
with similar results and the figure is representative of one
experiment.
Progressive hypoxia model of infection
Each strain was diluted to ,10
4 bacilli/ml, as determined by
OD600. Cultures were inoculated into individual test tubes
containing a magnetic stir bar ratio and a head-space air to
medium volume (HSR) of 0.5 and sealed with rubber stoppers.
The cultures were incubated upright at 37uC with stir-bars spun at
a speed sufficient for uniform suspension of organisms without
agitating the surface of the medium. The reduction and
decolorization of the methylene blue dye served as a visual
indicator of oxygen depletion sufficient to induce bacillary entry
into NRP stage 2 [32]. At designated time points, samples were
collected by piercing the rubber stoppers without introducing
atmospheric oxygen into the tubes, as assessed by maintenance of
the decolorized dye state.
Antibiotic exposure
Wild-type and MT0516::Tn strains were grown to mid-
exponential phase in supplemented Middlebrook 7H9 broth. For
determination of isoniazid minimum inhibitory concentration
(MIC), 10
5 organisms from each culture were grown for 14 days at
37uC in the presence of the following final concentrations of
isoniazid: 0, 0.03, 0.06, 0.12, 0.25, 0.5, 1, 2, 4, and 8 mg/ml. For
determination of rifampin MIC, 10
5 organisms from each culture
were grown for 14 days at 37uC in the presence of the following
final concentrations of rifampin: 0, 0.125, 0.25, 0.5, 1, 2, 4, and
8 mg/ml. Samples were incubated in standing tubes and the MIC
was defined as the lowest antibiotic concentration in which a
bacterial pellet was absent.
Growth kinetics in human macrophages
The growth of each strain in activated THP-1 cells was assessed
as previously described [56] with slight modifications. Each strain
was grown to mid-logarithmic phase in 7H9 Middlebrook broth
and diluted 100-fold, pelleted, washed twice in RPMI (GIBCO)
supplemented with 10% FBS and resuspended in complete RPMI
without antibiotics. Phorbol 12-myrisate-13-acetate (20nM)-acti-
vated THP-1 cells (ATCC) were infected with individual Mtb
cultures for 2 hours. The cells were washed twice with fresh RPMI
supplemented with 10% FBS and incubated with fresh antibiotic
free-media. The cells were lysed with Triton X-100 at predeter-
mined time points and the lysate was plated on Middlebrook 7H10
plates for colony enumeration of intracellular bacteria.
Animal studies
Female outbred Hartley guinea pigs (250–300 g) were pur-
chased from Charles River Labs (Wilmington, MA). Separate
groups of 20 female Hartley guinea pigs were infected with a
Madison chamber aerosol generation device (College of Engi-
neering Shops, University of Wisconsin, Madison, WI) calibrated
to deliver approximately 100 bacilli of MT0516::Tn, MT0516
Comp, or wild type into guinea pig lungs, as previously described
[57]. Four guinea pigs from each group were euthanized at Days
1, 14, 28, 56, and 84 after infection. At necropsy, lungs and spleens
were removed aseptically, weighed, and examined. Organs were
then homogenized for CFU enumeration and processed for
histology. Lungs were homogenized in 10–15 ml PBS using a
Kinematica Polytron Homogenizer with a 12-mm generator
(Brinkman) within a BSL-III Glovebox Cabinet (Germfree), as
previously described [33,58]. Serial tenfold dilutions of organ
homogenates were plated on 7H11 selective agar (BBL) except for
Day 1 lung samples, which were plated neat. Plates were
incubated at 37uC and CFU were counted 4 weeks later. At
various time points after infection, lung samples were fixed in 10%
PBS-buffered formalin, paraffin-embedded, and sectioned. Sec-
tions were stained with hematoxylin/eosin and Ziehl–Neelsen for
microscopy. The histopathological sections were reviewed by two
independent observers who were blinded to the study groups.
Statistical analysis
The mean of log-transformed lung CFU values, based on four
samples for each measure, were compared by the Student t-test. A
p-value of , .05 was considered statistically significant. The error
bars represent the Standard Deviation (SD). Statistical analysis of
gene expression studies was performed using three biological
replicates of each sample at each time point. Synthesized cDNA
was subjected to three technical replicates of PCR amplification
for each biological sample. Each individual reaction was compared
to a reaction lacking reverse transcriptase (background signal).
Melt curves were generated for each reaction and successful
reactions contained only one melt peak above threshold,
representing a single amplicon per reaction. Normalized technical
replicate values were averaged to generate a single value for each
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calculated for the three biological replicate values of each gene of
interest.
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